Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 2:07 AM
Ignite Modification Date: 2025-12-25 @ 2:07 AM
NCT ID: NCT03761160
Eligibility Criteria: Inclusion Criteria: Phase 1 * All recruited participants must have owned a smartphone for \>1 year * English-speaking. * Patients with prostate cancer aged between 40-75 years will be considered. * No specific timeframe after prostate cancer diagnosis will be required for these patients. * No limitations regarding their disease characteristics will be imposed (e.g. metastatic disease). * Patients may or may not be currently receiving treatment Staff members will be recruited from * Dana-Farber Cancer Institute Department of Medical Oncology, * Brigham and Women's Hospital, Department of Surgery. Staff members aged between 40-75 years old will be considered. Phase 2 * Men diagnosed with prostate cancer presenting to DF/BWHCC * About to initiate ADT for the first time will be considered. * Age range 40-75-years * The ability to walk 400 m * Medical clearance from their primary physician * English speaking * Cognitively alert * Literate * Ability to read or hear with or without contacts/glass and hearing aid * Ownership of a smartphone for \>1yr Exclusion Criteria: * Men who have been under a rigorous structured exercise regime, such as individuals who engage in more than 900 minutes of moderate physical activity per week in the last 6 months will not be considered * Post-ADT treatment * Planned systemic chemotherapy * Planned treatment with abiraterone or enzalutamide * Bone metastases * Acute illness * Any musculoskeletal, cardiovascular, or neurologic disorders that could inhibit or put them at risk from exercising * Subordinates to the PI
Healthy Volunteers: False
Sex: MALE
Minimum Age: 40 Years
Maximum Age: 75 Years
Study: NCT03761160
Study Brief:
Protocol Section: NCT03761160